SCHEMBL7107879

SCHEMBL7107879

CCc1cccc(C(=O)C(O)O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.47
KAT6A Q92794 2/20 0.46
SMYD3 Q9H7B4 1/20 0.46
CNR2 P34972 1/20 0.46
LOXL2 Q9Y4K0 1/20 0.45
CYP4F2 P78329 3/20 0.44
CYP4A11 Q02928 3/20 0.44
PTGS2 P35354 1/20 0.43
SLC7A5 Q01650 2/20 0.42
FOLH1 Q04609 1/20 0.42
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 1/20 0.40
TP53 P04637 1/20 0.40
PKM P14618 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11062513 0.87 BCL2 (0.46) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL5547633 0.86 KAT6A (0.48) KAT6ACNR2LOXL2CYP4F2CYP4A11
SCHEMBL7756387 0.86 BCL2 (0.49) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL10277237 0.85 BCL2 (0.47) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL3362947 0.84 GSK3B (0.51) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL11065158 0.83 LOXL2 (0.47) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL9041418 0.82 SMYD3 (0.47) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL19707742 0.82 BCL2 (0.45) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL8400086 0.82 SMYD3 (0.47) BCL2KAT6ASMYD3CNR2LOXL2
SCHEMBL11070699 0.82 SMYD3 (0.44) BCL2KAT6ASMYD3CNR2LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347784-A2 SIMULTANEOUS DUAL ISOTOPE IMAGING OF CARDIAC PERFUSION AND CARDIAC INFLAMMATION Bristol-Myers Squibb Pharma Company (US) 2003-10-01 EP disclosed
WO-2002036173-A2 SIMULTANEOUS DUAL ISOTOPE IMAGING OF CARDIAC PERFUSION AND CARDIAC INFLAMMATION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-05-10 WO disclosed
EP-0999856-A2 RADIOPHARMACEUTICALS FOR IMAGING INFECTION AND INFLAMMATION Du Pont Pharmaceuticals Company (US) 2000-05-17 EP disclosed
CN-1239895-A Radiopharmaceuticals for imaging sites of infection and inflammation DU PONT MERCK PHARMA (US) 1999-12-29 CN disclosed
WO-1998015295-A2 RADIOPHARMACEUTICALS FOR IMAGING INFECTION AND INFLAMMATION DUPONT PHARMACEUTICALS COMPANY (US) 1998-04-16 WO disclosed
EP-0349489-A2 Organic macromolecular material containing a hydrazone-based metal complex pigment CIBA-GEIGY AG (CH) 1990-01-03 EP disclosed